Bamlanivimab for Covid-19 in Kidney Transplant Patients
Barriers to Living Kidney Donation: A Closer Look at Declined Donors
Baseline Levels of Dd-cf Dna After Pancreas Transplantation: Using Dd-cfdna as an Indicator for Pancreas Rejection and Biopsy Avoidance
Basiliximab versus Alemtuzumab: The Association Between Induction Agent and Airway Complications Following Lung Transplantation
Belatacept Conversion in Elderly Renal Transplant Recipients
Belatacept Conversion in Proteinuric Renal Transplant Recipients: An Interventional Multi-Center Trial
Belatacept Exposure Not Associated With Rejection. Can Doses be Lowered without Compromising Efficacy?
Belatacept for Kidney Transplantation in the Age of Covid19, is it Safe?
Belatacept Pharmacokinetic Analysis Comparing Belatacept Early Steroid Withdrawal Trial (BEST) with Benefit and Benefit-ext Trials
Belatacept Pharmacokinetics in Patients with and without Infection
- « Previous Page
- 1
- …
- 9
- 10
- 11
- 12
- 13
- …
- 115
- Next Page »